A close-up of a doctor's hands touching a pill.

This overview shares key insights from our report on Phase I–III clinical trials that initiated in 2022 across all therapeutic areas, as well as in-depth analyses into the key diseases, players, and geographies that impact the pharmaceutical industry. In 2022, the roller coaster resumed as the healthcare industry continued to be influenced by the global economy and political climate.

Related resources

A close-up of a doctor's hands touching a pill.
NOV 03, 2023
ホワイトペーパー
研究開発支援サービス

The Annual Clinical Trials Roundup

This report focuses on an overview of Phase I–III clinical trials that initiated in 2022 across all therapeutic areas.

a man and woman in white coat looking at a computer screen
MAY 01, 2023
ホワイトペーパー
研究開発支援サービス

2022 Completed Trials: A Roller Coaster Ride for Industry Sponsors

In 2022, Trialtrove recorded 3,881 industry-sponsored Phase I-IV clinical trials that either reached completed status or reported primary endpoints.

APR 01, 2023
ホワイトペーパー
研究開発支援サービス

Citeline Pharma R&D Annual Review 2023

The Pharma R&D Annual Review 2023 assesses industry trends by examining the pipeline by company, therapeutic area, disease, target, and drug type.